Which SGLT2 are cardioprotective?
There is compelling evidence that sodium–glucose cotransporter 2 (SGLT2) inhibitors exert cardioprotective and renoprotective effects that are far greater than expected based on their effects on glycemia or glycosuria.
Is acarbose a SGLT2 inhibitor?
Antidiabetic drugs include acarbose, metformin, and sodium-glucose cotransporter 2 (SGLT2) inhibitors, which are considered as types of drugs that can induce direct glucose excretion from the body.
Where are SGLT?
Sodium-dependent glucose cotransporters (or sodium-glucose linked transporter, SGLT) are a family of glucose transporter found in the intestinal mucosa (enterocytes) of the small intestine (SGLT1) and the proximal tubule of the nephron (SGLT2 in PCT and SGLT1 in PST).
Is empagliflozin a cardioprotective?
Selective inhibitors of SGLT-2 such as empagliflozin were found to exert unexpected cardio- and nephroprotective effects in clinical trials and thus have become important therapeutic agents in type II diabetes, especially in patients with preexisting cardiac or renal disease.
Which is the best SGLT2 inhibitor?
Current Selective SGLT2 Inhibitors Of the three FDA approved drugs, empagliflozin has the greatest selectivity for SGLT2 compared to SGLT1, while canagliflozin is the least selective (5).
What is the function of SGLT1?
SGLT1 is responsible for the sodium-dependent, active uptake of glucose across the apical membrane of the small intestine. In the kidney, SGLT1 is responsible for about 10% of the tubular glucose reabsorption [7].
What 2 molecules do the Sglts transport?
Sodium-glucose cotransporter (SGLT) activity mediates apical sodium and glucose transport across cell membranes.
Is exenatide a sulfonylurea?
Exenatide (Byetta) is a novel, synthetic, incretin mimetic, glucoregulatory peptide approved in the US and Europe for the treatment of patients with type 2 diabetes mellitus who have inadequate glycaemic control despite receiving treatment with maximum tolerated doses of metformin and/or a sulfonylurea.